US Edition
Millions of Men Could Benefit From Faster Scan to Diagnose Prostate Cancer
The two-part MRI scan cuts time nearly in half and reduces costs by 47% while maintaining equal accuracy in detecting prostate cancer, study finds.
- On Wednesday 10 September 2025, a clinical trial published in JAMA showed a faster two-part MRI scan diagnosed prostate cancer as effectively as the current three-part scan.
- The trial, led by UCL and University of Birmingham, arose from growing demand for prostate MRI scans amid a predicted surge in cases over the next 20 years.
- The two-part scan cuts imaging time to 15-20 minutes from 30-40 minutes, reduces the need for a doctor present, and costs £145 compared to £273 for the three-part scan.
- Dr Matthew Hobbs called the results a "hugely important step" and urged NICE to review guidelines promptly so MRIs become quicker, cheaper, and less onerous for men.
- The findings could expand MRI accessibility and efficiency but experts urge caution due to study limitations, advocating further research including the upcoming Transform trial to guide screening policy.
22 Articles
22 Articles
The Independent
Millions could benefit from faster scan to diagnose prostate cancer – study
The scan only takes 15 to 20 minutes and could save the NHS money, researchers say.
Millions of men could benefit from faster scan to diagnose prostate cancer
A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30–40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, according to clinical trial results led by UCL, UCLH and the University of Birmingham.
expert reaction to study comparing use of two-part MRI scan to three-part MRI scans in the diagnosis of prostate cancer
A study published in JAMA compares the use of biparametric vs multiparametric MRI for prostate cancer diagnosis. Prof Freddie Hamdy, Nuffield Professor of Surgery and Professor of Urology, University of Oxford, and Prof Jenny Donovan, Professor of Social Medicine, University of Bristol, said: “The PRIME study shows that biparametric MRI allows a rate of prostate cancer detection which is non-inferior to the conventional longer and more expens…
Coverage Details
Bias Distribution
- 57% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
